AI-generated interactive video instructions for mitral valve repair

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center, randomized trial at Cedars-Sinai comparing an AI-generated interactive peri-operative video education program to standard education in a 1:1 ratio for adults undergoing elective isolated mitral valve repair. Participants will watch the assigned videos and complete questionnaires, with outcomes tracked through hospital records and follow-up. The primary outcome is total unplanned healthcare utilization, a composite of readmissions, emergency department visits, and unplanned outpatient visits; secondary outcomes include length of stay and cardiovascular medication adherence, and tertiary outcomes include anxiety, satisfaction, and discharge location. All procedures and enrollment take place at the Cedars-Sinai Smidt Heart Institute in Los Angeles.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adult patients ≥ 18 years planned for elective, isolated MV repair.
2. Provide Informed consent

Exclusion Criteria:

1. Insufficient computer/smart device knowledge. Children or caregivers can assist, but patients should be able to access their own email or text messages and navigate to the internet to use the provided AI generated educational intervention.
2. Inconsistent access to a smart device with internet connection throughout the study period.
3. Inability to speak, read, and understand English or Spanish
4. Need for any concomitant procedure at the time of MV repair

Where it's running

• Cedars Sinai Medical Center Smidt Heart Institute
  Los Angeles, California, United States Recruiting

Study contacts

• Principal investigator: Joanna Chikwe, MD — Cedars-Sinai Medical Center
• Study coordinator: Aminah Sallam, MD
• Email: aminah.sallam@cshs.org
• Phone: 3104233277

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing aspirin and warfarin after mitral valve repair surgery

  This study is testing whether giving aspirin or warfarin right after mitral valve repair surgery helps patients stay safe and healthy in the months that follow.

  Recruiting Phase 4 Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT06738992

• Fisetin for Lung Health in Older Adults

  Researchers are testing whether a short course of the supplement fisetin can improve lung function and aging-related biomarkers in people 60 and older, including both smokers and never-smokers.

  Recruiting Phase 2 Cedars-Sinai Medical Center · Los Angeles, California · NCT07676435

• Transcatheter vs. Surgical Repair for Degenerative Mitral Valve Disease

  This study compares TEER, a catheter-based repair, with traditional surgical mitral repair in people aged 60 and older with degenerative mitral valve disease to see which approach works better in the long run.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT07605715

• Combining IV immunotherapy with liver-directed procedures to downstage hepatocellular carcinoma

  This tests whether giving IV immunotherapy (tremelimumab plus durvalumab) together with a liver-directed procedure (Y90, TACE, or RFA) can shrink or control hepatocellular carcinoma in adults with intermediate or advanced disease so more people may become eligible for liver transplant.

  Recruiting Phase 2 Cedars-Sinai Medical Center · Los Angeles, California · NCT07489976

• TAVR vs SAVR for severe bicuspid aortic valve stenosis

  This trial tests whether TAVR or SAVR works better for people with severe bicuspid aortic valve stenosis.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT07413965

• Bupivacaine with Epinephrine Sprayed Under the Diaphragm During Laparoscopy

  This study tests whether spraying bupivacaine with epinephrine under the diaphragm during laparoscopic gynecologic surgery reduces postoperative shoulder pain.

  Recruiting Phase 4 Cedars-Sinai Medical Center · Los Angeles, California · NCT07400146

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.